Literature DB >> 25953257

Obesity induced by high fat diet attenuates postinfarct myocardial remodeling and dysfunction in adult B6D2F1 mice.

Marcos Poncelas1, Javier Inserte2, Úrsula Vilardosa1, Antonio Rodriguez-Sinovas1, Jordi Bañeras1, Rafael Simó3, David Garcia-Dorado4.   

Abstract

Obesity is a major risk factor for cardiovascular morbidity and mortality. However, some studies suggest that among patients with established cardiovascular disease, obesity is associated with better prognosis, a phenomenon described as the obesity paradox. In this study we tested the hypothesis that obesity with hyperinsulinemia and without hyperglycemia attenuates the impact of transient coronary occlusion on left ventricular remodeling and function. B6D2F1 mice from both genders fed with a high fat diet (HFD) or control diet for 6 months were subjected to 45 min of coronary occlusion and 28 days of reperfusion. Left ventricular dimensions and function were assessed by serial echocardiography, and infarct size was determined by Picrosirius red staining. HFD mice developed obesity with hypercholesterolemia and hyperinsulinemia in the absence of hyperglycemia or hypertension. During the period of feeding, no changes were observed in ventricular mass, volume or function, or in vascular reactivity. HFD attenuated the consequences of transient coronary occlusion as shown by a marked reduction in infarct size (51%, P = 0.021) and cardiac dilation, as well as improved left ventricular function as compared to control diet animals. These effects were associated with enhanced reperfusion injury salvage kinases (RISK) pathway function in HFD hearts shown as increased Akt and GSK3β phosphorylation. These results demonstrate that dietary obesity without hyperglycemia or hypertension attenuates the impact of ischemia/reperfusion injury in association with increased insulin signaling and RISK activation. This study provides experimental support to the controversial concept of the obesity paradox in humans.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Insulin; Myocardial infarction; Obesity; Remodeling

Mesh:

Substances:

Year:  2015        PMID: 25953257     DOI: 10.1016/j.yjmcc.2015.04.023

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  11 in total

Review 1.  Obesity and Cardiometabolic Defects in Heart Failure Pathology.

Authors:  Ganesh V Halade; Vasundhara Kain
Journal:  Compr Physiol       Date:  2017-09-12       Impact factor: 9.090

2.  Interaction of Obesity and Hypertension on Cardiac Metabolic Remodeling and Survival Following Myocardial Infarction.

Authors:  Alan J Mouton; Elizabeth R Flynn; Sydney P Moak; Xuan Li; Alexandre A da Silva; Zhen Wang; Jussara M do Carmo; Michael E Hall; John E Hall
Journal:  J Am Heart Assoc       Date:  2021-03-05       Impact factor: 5.501

3.  Comparison of 2-year mortality according to obesity in stabilized patients with type 2 diabetes mellitus after acute myocardial infarction: results from the DIAMOND prospective cohort registry.

Authors:  Ki-Bum Won; Seung-Ho Hur; Yun-Kyeong Cho; Hyuck-Jun Yoon; Chang-Wook Nam; Kwon-Bae Kim; Jang-Ho Bae; Dong-Ju Choi; Young-Keun Ahn; Jong-Seon Park; Hyo-Soo Kim; Rak-Kyeong Choi; Donghoon Choi; Joon-Hong Kim; Kyoo-Rok Han; Hun-Sik Park; So-Yeon Choi; Jung-Han Yoon; Hyeon-Cheol Kwon; Seung-Un Rha; Kyung-Kuk Hwang; Do-Sun Lim; Kyung-Tae Jung; Seok-Kyu Oh; Jae-Hwan Lee; Eun-Seok Shin; Kee-Sik Kim
Journal:  Cardiovasc Diabetol       Date:  2015-10-15       Impact factor: 9.951

4.  Effect of high fat diet on pulmonary expression of parathyroid hormone-related protein and its downstream targets.

Authors:  Learta Oruqaj; Svenja Forst; Rolf Schreckenberg; Javier Inserte; Marcos Poncelas; Jordi Bañeras; David Garcia-Dorado; Susanne Rohrbach; Klaus-Dieter Schlüter
Journal:  Heliyon       Date:  2016-10-27

Review 5.  PCSK9 in Myocardial Infarction and Cardioprotection: Importance of Lipid Metabolism and Inflammation.

Authors:  Ioanna Andreadou; Maria Tsoumani; Gemma Vilahur; Ignatios Ikonomidis; Lina Badimon; Zoltán V Varga; Péter Ferdinandy; Rainer Schulz
Journal:  Front Physiol       Date:  2020-11-12       Impact factor: 4.566

6.  Stress-induced body weight loss and improvements in cardiometabolic risk factors do not translate to improved myocardial ischemic tolerance in western diet-fed mice.

Authors:  Kyle Hatton-Jones; Amanda J Cox; Jason N Peart; John P Headrick; Eugene F du Toit
Journal:  Physiol Rep       Date:  2022-01

7.  Sex- and strain-specific effects of mitochondrial uncoupling on age-related metabolic diseases in high-fat diet-fed mice.

Authors:  Leigh Goedeke; Kelsey N Murt; Andrea Di Francesco; João Paulo Camporez; Ali R Nasiri; Yongliang Wang; Xian-Man Zhang; Gary W Cline; Rafael de Cabo; Gerald I Shulman
Journal:  Aging Cell       Date:  2022-01-28       Impact factor: 9.304

Review 8.  An Overview of Murine High Fat Diet as a Model for Type 2 Diabetes Mellitus.

Authors:  Ahlke Heydemann
Journal:  J Diabetes Res       Date:  2016-07-31       Impact factor: 4.011

9.  Evaluation of the impact of statin therapy on the obesity paradox in patients with acute myocardial infarction: A propensity score matching analysis from the Korea Acute Myocardial Infarction Registry.

Authors:  Ki-Bum Won; Seung-Ho Hur; Chang-Wook Nam; Soe Hee Ann; Gyung-Min Park; Sang-Gon Lee; Hyo-Eun Kim; Yun-Kyeong Cho; Hyuck-Jun Yoon; Hyoung-Seob Park; Hyungseop Kim; Seongwook Han; Myung-Ho Jeong; Young-Keun Ahn; Seung-Woon Rha; Chong-Jin Kim; Myeong-Chan Cho; Hyo-Soo Kim; Shung-Chull Chae; Kee-Sik Kim; Young-Jo Kim; Kwon-Bae Kim; Philip Barter
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

10.  Human Lysyl Oxidase Over-Expression Enhances Baseline Cardiac Oxidative Stress but Does Not Aggravate ROS Generation or Infarct Size Following Myocardial Ischemia-Reperfusion.

Authors:  Laura Valls-Lacalle; Lídia Puertas-Umbert; Saray Varona; José Martínez-González; Cristina Rodríguez; Antonio Rodríguez-Sinovas
Journal:  Antioxidants (Basel)       Date:  2021-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.